New trends in inflammatory bowel disease epidemiology and disease course in Eastern Europe

Digestive and Liver Disease

Volumn 45, Issue 4, 2013, Pages 269-276

  Lovasz, Barbara D ^a   Golovics, Petra A ^a   Vegh, Zsuzsanna ^a   Lakatos, Peter L ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Crohn's disease; Disease course; IBD; Incidence; Prevalence; Ulcerative colitis

Indexed keywords

IMMUNOMODULATING AGENT; STEROID;

BOSNIA AND HERZEGOVINA; CANCER RISK; CHILDHOOD DISEASE; COLON RESECTION; COLORECTAL CANCER; CROATIA; CROHN DISEASE; CZECH REPUBLIC; ENTERITIS; ESTONIA; EUROPE; FOLLOW UP; HUMAN; HUNGARY; INCIDENCE; LITHUANIA; MOLDOVA; POLAND; PRIORITY JOURNAL; PROCTITIS; REVIEW; RUSSIAN FEDERATION; SLOVAKIA; STEROID THERAPY; ULCERATIVE COLITIS;

COLITIS, ULCERATIVE; COLORECTAL NEOPLASMS; CROHN DISEASE; EUROPE, EASTERN; HUMANS; INCIDENCE; PREVALENCE;

EID: 84875269405     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2012.08.020     Document Type: Review

References (68)

1. Lakatos P.L. Recent trends in the epidemiology of inflammatory bowel diseases: up or down?. World Journal of Gastroenterology 2006, 12:6102-6108.
2. Molodecky N.A., Soon I.S., Rabi D.M., et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012, 142:46-54.
3. Loftus E.V. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 2004, 126:1504-1517.
4. Loftus C.G., Loftus E.V., Harmsen W.S., et al. Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000. Inflammatory Bowel Diseases 2007, 13:254-261.
5. Shivananda S., Lennard-Jones J., Logan R., et al. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European collaborative study on inflammatory bowel disease (EC-IBD). Gut 1996, 39:690-697.
6. Munkholm P., Langholz E., Nielsen O.H., et al. Incidence and prevalence of Crohn's disease in the county of Copenhagen, 1962-87: a sixfold increase in incidence. Scandinavian Journal of Gastroenterology 1992, 27:609-614.
7. Vind I., Riis L., Jess T., et al. Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003-2005: a population-based study from the Danish Crohn colitis database. American Journal of Gastroenterology 2006, 101:1274-1282.
8. Lakatos L., Kiss L.S., David G., et al. Incidence, disease phenotype at diagnosis, and early disease course in inflammatory bowel diseases in Western Hungary, 2002-2006. Inflammatory Bowel Diseases 2011, 17:2558-2565.
9. Prideaux L., Kamm M.A., De Cruz P.P., et al. Inflammatory bowel disease in Asia - a systematic review. Journal of Gastroenterology and Hepatology 2012, 27:1266-1280.
10. Burisch J., Xia B., Cukovic-Cavka S., et al. Is there and east-west gradient in the incidence of IBD in Europe? And further far east in China? First results from the Epicom study. Gastroenterology 2012, 142(Suppl. IV):Mo1004.
11. Cosnes J., Cattan S., Blain A., et al. Long-term evolution of disease behavior of Crohn's disease. Inflammatory Bowel Diseases 2002, 8:244-250.
12. Bernstein C.N., Loftus E.V., Ng S.C., et al. Hospitalizations and surgery in Crohn's disease. Gut 2012, 61:622-629.
13. Jess T., Riis L., Vind I., et al. Changes in clinical characteristics, course, and prognosis of inflammatory bowel disease during the last 5 decades: a population-based study from Copenhagen, Denmark. Inflammatory Bowel Diseases 2007, 13:481-489.
14. Solberg I.C., Lygren I., Jahnsen J., et al. Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study). Scandinavian Journal of Gastroenterology 2009, 44:431-440.
15. Hoie O., Wolters F.L., Riis L., et al. Low colectomy rates in ulcerative colitis in an unselected European cohort followed for 10 years. Gastroenterology 2007, 132:507-515.
16. Jess T., Rungoe C., Peyrin-Biroulet L. Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies. Clinical Hepatology and Gastroenterology 2012, 10:639-645.
17. Pedersen N., Duricova D., Elkjaer M., et al. Risk of extra-intestinal cancer in inflammatory bowel disease: meta-analysis of population-based cohort studies. American Journal of Gastroenterology 2010, 105:1480-1487.
18. Vucelic B., Korac B., Sentic M., et al. Epidemiology of Crohn's disease in Zagreb, Yugoslavia: a ten-year prospective study. International Journal of Epidemiology 1991, 20:216-220.
19. Vucelic B., Korac B., Sentic M., et al. Ulcerative colitis in Zagreb, Yugoslavia: a ten-year prospective study. International Journal of Epidemiology 1991, 20:1043-1047.
20. Jovanovic Z. Epidemiology of Crohn's disease in the Rijeka-Istra region. Lijecnicki Vjesnik 1999, 121:8-13.
21. Sincic B.M., Vucelic B., Persic M., et al. Incidence of inflammatory bowel disease in Primorsko-Goranska county, Croatia, 2000-2004. Scandinavian Journal of Gastroenterology 2006, 41:437-444.
22. Lakatos L., Mester G., Erdelyi Z., et al. Striking elevation in incidence and prevalence of inflammatory bowel disease in a province of western Hungary between1997-2001. World Journal of Gastroenterology 2004, 10:404-409.
23. Pavlovic-Calic N., Salkic N.N., Gegic A., et al. Crohn's disease in Tuzla region of Bosnia and Herzegovina: a 12-year study (1995-2006). International Journal of Colorectal Disease 2008, 23:957-964.
24. Salkic N.N., Pavlovic-Calic N., Gegic A., et al. Ulcerative colitis in the Tuzla region of Bosnia and Herzegovina between 1995 and 2006: epidemiological and clinical characteristics. European Journal of Gastroenterology and Hepatology 2010, 22:346-353.
25. Nedbal J., Mařatka Z. Colitis ulcerosa v československu. Vnitřní Lékařství 1967, 11:1054-1063.
26. Bitter J., Dyrhonová V., Komárková O., et al. Nespecifické střevní záněty v české republice. československá Gastroenterologie a Výľiva 1992, 46:313-321.
27. Kull K., Salupere R., Uibo R., et al. Antineutrophil cytoplasmic antibodies in Estonian patients with inflammatory bowel disease: prevalence and diagnostic role. Hepato-Gastroenterology 1998, 45:2132-2137.
28. Salupere R. Inflammatory bowel disease in Estonia: a prospective epidemiologic study 1993-1998. World Journal of Gastroenterology 2001, 7:387-388.
29. Kiudelis G., Zvirbliene A., Sventoraityte J., et al. Referral epidemiology of ulcerative colitis and Crohn's disease in Kaunas region, Lithuania: one year prospective study. Journal of Crohn's and Colitis Supplements 2008, 2:70.
30. Wierska-Drapalo A., Jaroszewicz J., Flisiak R., et al. Epidemiological characteristics of inflammatory bowel disease in North-Eastern Poland. World Journal of Gastroenterology 2005, 11:2630-2633.
31. Gheorghe C., Pascu O., Gheorghe L., et al. Epidemiology of inflammatory bowel disease in adults who refer to gastroenterology care in Romania: a multicenter study. European Journal of Gastroenterology and Hepatology 2004, 16:1153-1159.
32. Prikazka M., Letkovicova M., Matejickova V. Crohns disease in Slovakia: prevalence, socioeconomic and psychological analysis. European Journal of Epidemiology 1998, 14:49-53.
33. Kolek A., Janout V., Tichy M., et al. The incidence of inflammatory bowel disease is increasing among children 15 years old and younger in the Czech Republic. Journal of Pediatric Gastroenterology and Nutrition 2004, 38:362-363.
34. Kolek A., Janout V., Mathonová J. Increasing incidence of inflammatory bowel disease in children and adolescents in six districts of Northern and Central Moravia [Czech Republic]. Ceská a Slovenská Gastroenterologie a Hepatologie 2001, 22:173-177.
35. Pozler O., Maly J., Bonova O., et al. Incidence of Crohn's disease in the Czech Republic in the years 1990 to 2001 and assessment of pediatric population with inflammatory bowel disease. Journal of Pediatric Gastroenterology and Nutrition 2006, 42:186-189.
36. Lakatos P.L., David G., Pandur T., et al. IBD in the elderly population: results from a population-based study in Western Hungary, 1977-2008. Journal of Crohn's and Colitis 2011, 5:5-13.
37. Karolewska-Bochenek K., Lazowska-Przeorek I., Albrecht P., et al. Epidemiology of inflammatory bowel disease among children in Poland. A prospective population-based, 2-year study, 2002-2004. Digestion 2009, 79:121-129.
38. Orel R., Kamhi T., Vidmar G., et al. Epidemiology of pediatric chronic inflammatory bowel disease in central and western Slovenia, 1994-2005. Journal of Pediatric Gastroenterology and Nutrition 2009, 48:579-586.
39. Lakatos P.L., Golovics P.A., David G., et al. Has there been a change in the natural history of Crohn's disease? Surgical rates and medical management in a population-based inception cohort from Western Hungary between 1977-2009. American Journal of Gastroenterology 2012, 107:579-588.
40. Solberg I.C., Vatn M.H., Høie O., et al. Clinical course in Crohn's disease: results of a Norwegian population-based ten-year follow-up study. Clinical Gastroenterology and Hepatology 2007, 5:1430-1438.
41. Vernier-Massouille G., Balde M., Salleron J., et al. Natural history of pediatric Crohn's disease: a population-based cohort study. Gastroenterology 2008, 135:1106-1113.
42. Bernell O., Lapidus A., Hellers G. Risk factors for surgery and postoperative recurrence in Crohn's disease. Annals of Surgery 2000, 231:38-45.
43. Nguyen G.C., Nugent Z., Shaw S., et al. Outcomes of patients with Crohn's disease improved from 1988 to 2008 and were associated with increased specialist care. Gastroenterology 2011, 141:90-97.
44. Ramadas A.V., Gunesh S., Thomas G.A., et al. Natural history of Crohn's disease in a population-based cohort from Cardiff (1986-2003): a study of changes in medical treatment and surgical resection rates. Gut 2010, 59:1200-1206.
45. Eaden J.A., Abrams K.R., Mayberry J.F. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001, 48:526-535.
46. Lakatos L., Mester G., Erdelyi Z., et al. Risk factors for ulcerative colitis associated colorectal cancer in a Hungarian cohort of patients with ulcerative colitis: results of a population-based study. Inflammatory Bowel Diseases 2006, 12:205-211.
47. Söderlund S., Granath F., Broström O., et al. Inflammatory bowel disease confers a lower risk of colorectal cancer to females than to males. Gastroenterology 2010, 138:1697-1703.
48. Warren S., Sommers S.C. Cicatrizing enteritis (regional enteritis) as a pathologic entity: analysis of one hundred and twenty cases. American Journal of Pathology 1948, 24:475-501.
49. Ekbom A., Helmick C., Zack M., et al. Increased risk of large bowel cancer in Crohn's disease with colonic involvement. Lancet 1990, 336:357-359.
50. Gillen C.D., Andrews H.A., Prior P., et al. Crohn's disease and colorectal cancer. Gut 1994, 35:651-655.
51. Jess T., Loftus E.V., Velayos F.S., et al. Risk of intestinal cancer in inflammatory bowel disease: a population-based study from Olmsted county, Minnesota. Gastroenterology 2006, 130:1039-1046.
52. Gollop J.H., Phillips S.F., Melton L.J., et al. Epidemiologic aspects of Crohn's disease: a population-based study in Olmsted County, Minnesota, 1943-1982. Gut 1988, 29:49-56.
53. Jess T., Winther K.V., Munkholm P., et al. Intestinal and extra-intestinal cancer in Crohn's disease: follow-up of a population-based cohort in Copenhagen County, Denmark. Alimentary Pharmacology and Therapeutics 2004, 19:287-293.
54. Ekbom A., Helmick C., Zack M., et al. Extracolonic malignancies in inflammatory bowel disease. Cancer 1991, 67:2015-2019.
55. von Roon A.C., Reese G., Teare J., et al. The risk of cancer in patients with Crohn's disease. Diseases of the Colon and Rectum 2007, 50:839-855.
56. Lakatos P.L., David G., Pandur T., et al. Risk of colorectal cancer and small bowel adenocarcinoma in Crohn's disease: a population-based study from Western Hungary 1977-2008. Journal of Crohn's and Colitis 2011, 5:122-128.
57. Mellemkjaer L., Johansen C., Grindley G., et al. Crohn's disease and cancer risk (Denmark). Cancer Causes and Control 2000, 11:145-150.
58. Fireman Z., Grossman A., Lilos P., et al. Intestinal cancer in patients with Crohn's disease. A population study in central Israel. Scandinavian Journal of Gastroenterology 1989, 24:346-350.
59. Bernstein C.N., Blanchard J.F., Kliewer E., et al. Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer 2001, 91:854-862.
60. Lewis J.D., Bilker W.B., Brensinger C., et al. Inflammatory bowel disease is not associated with an increased risk of lymphoma. Gastroenterology 2001, 121:1080-1087.
61. Askling J., Brandt L., Lapidus A.R., et al. Risk of haematopoietic cancer in patients with inflammatory bowel disease. Gut 2005, 54:617-622.
62. Kandiel A., Fraser A.G., Korelitz B.I., et al. Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine. Gut 2005, 54:1121-1125.
63. Beaugerie L., Brousse N., Bouvier A.M., et al. Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study. Lancet 2009, 374:1617-1625.
64. Lakatos P.L., Lovasz B.D., David G., et al. The risk of lymphoma and immunomodulators in patients with inflammatory bowel diseases. Results from a population-based cohort in Eastern Europe. Journal of Crohn's and Colitis 2012, 6. 10.1016/j.crohns.2012.06.011.
65. Gilat T., Hacohen D., Lilos P., et al. Childhood factors in ulcerative colitis and Crohn's disease. An international cooperative study. Scandinavian Journal of Gastroenterology 1987, 22:1009-1024.
66. Meggyesi N., Kiss L.S., Koszarska M., et al. NKX2-3 and IRGM variants are associated with disease susceptibility to inflammatory bowel diseases in Eastern European patients. World Journal of Gastroenterology 2010, 16:5233-5240.
67. Lakatos P.L., Szamosi T., Szilvasi A., et al. ATG16L1 and IL-23 receptor (IL-23R) genes are associated with disease susceptibility in Hungarian CD patients. Digestive and Liver Disease 2008, 40:867-873.
68. Lakatos P.L., Papp M., Rieder F. Serologic anti-glycan antibodies in inflammatory bowel disease. American Journal of Gastroenterology 2011, 106:406-412.